Yunnan Watson Biotechnology Co., Ltd. published a prospectus today and officially launched the A share IPO process.
Watson’s publicly issued 25 million shares this time. The company is a biopharmaceutical company specializing in R&D, production and sales of human vaccine products. The funds raised will be invested in the expansion project of the Vaccine R&D Center, the freeze-dried demonstration projects of Group A and C meningococcal polysaccharide conjugate vaccines, and the expansion project of the second phase of the Yuxi Watson Vaccine Industrial Park and the influenza virus split vaccine industry. Construction projects, information construction projects, marketing network expansion and brand building projects, and other working capital projects related to main business.

Fabric Filter Cartridges

Mc Series Pluse Filter with Cioth Bag,Jet Pulse Air Filters,Liquid Filter Bag

Mixing Equipment Co., Ltd. ,